{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:54:31Z","timestamp":1793163271758,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejphar.2025.178086","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:32:57Z","timestamp":1755736377000},"page":"178086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Unveiling anticancer peptides; from the mechanisms of action to their development through artificial intelligence"],"prefix":"10.1016","volume":"1005","author":[{"given":"Alexandra R.","family":"Collins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilis","family":"Paspaliaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ikhtear","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Spathakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2066-4782","authenticated-orcid":false,"given":"George","family":"Kolios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178086_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.109750","article-title":"A robust ensemble framework for anticancer peptide classification using multi-model voting approach","volume":"188","author":"Abbas","year":"2025","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejphar.2025.178086_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/9749363","article-title":"Development of peptide-based vaccines for cancer","volume":"2022","author":"Abd-Aziz","year":"2022","journal-title":"J. Oncol."},{"issue":"12","key":"10.1016\/j.ejphar.2025.178086_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12124","article-title":"Sub-acute and sub-chronic toxicity assessment of the antimicrobial peptide dermaseptin B2 on biochemical, haematological and histopathological parameters in BALB\/c mice and albino wistar rats","volume":"8","author":"Abdille","year":"2022","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.ejphar.2025.178086_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa153","article-title":"AntiCP 2.0: an updated model for predicting anticancer peptides anticancer peptides","volume":"22","author":"Agrawal","year":"2020","journal-title":"Briefings Bioinf."},{"issue":"16","key":"10.1016\/j.ejphar.2025.178086_bib5","doi-asserted-by":"crossref","first-page":"15249","DOI":"10.1007\/s00432-023-05144-9","article-title":"Recent advances and applications of peptide\u2013agent conjugates for targeting tumor cells","volume":"149","author":"Alamdari-palangi","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ejphar.2025.178086_bib6","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.3390\/ijms25126529","article-title":"Modeling the binding of anticancer peptides and Mcl-1","volume":"25","author":"Alhammadi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ejphar.2025.178086_bib7","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.arabjc.2014.05.037","article-title":"Total synthesis and anticancer activity of a cyclic heptapeptide from marine sponge using water soluble peptide coupling agent EDC","volume":"12","author":"Anand","year":"2019","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejphar.2025.178086_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1359261","article-title":"Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues","volume":"15","author":"Appiah","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178086_bib9","article-title":"Find a clinical trial","year":"2023","journal-title":"Australian Clinical Trials"},{"issue":"8","key":"10.1016\/j.ejphar.2025.178086_bib10","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.imbio.2012.12.002","article-title":"The effect of alloferon on the enhancement of NK cell cytotoxicity against cancer via the up-regulation of perforin\/granzyme B secretion","volume":"218","author":"Bae","year":"2013","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178086_bib11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.drudis.2017.02.001","article-title":"The importance of the glycosylation of antimicrobial peptides: natural and synthetic approaches","volume":"22","author":"Bednarska","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2025.178086_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mrfmmm.2014.03.005","article-title":"Apoptosis inducing lead compounds isolated from marine organisms of potential relevance in cancer treatment","volume":"768","author":"Beesoo","year":"2014","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"issue":"19","key":"10.1016\/j.ejphar.2025.178086_bib13","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.3390\/cancers16193254","article-title":"Short peptides as powerful arsenal for smart fighting cancer","volume":"16","author":"Bojarska","year":"2024","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.ejphar.2025.178086_bib14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/pharmaceutics12111045","article-title":"CancerGram: an effective classifier for differentiating anticancer from antimicrobial peptides","volume":"12","author":"Burdukiewicz","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejphar.2025.178086_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/biom10020247","article-title":"Melittin\u2014A natural peptide from bee venom which induces apoptosis in human leukaemia cells","volume":"10","author":"Ceremuga","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib17","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1038\/s41598-021-82513-9","article-title":"Improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method","volume":"11","author":"Charoenkwan","year":"2021","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.ejphar.2025.178086_bib18","doi-asserted-by":"crossref","first-page":"12316","DOI":"10.1074\/jbc.M413406200","article-title":"Rational design of \u03b1-Helical antimicrobial peptides with enhanced activities and specificity\/therapeutic index","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178086_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116709","article-title":"The role and future prospects of artificial intelligence algorithms in peptide drug development","volume":"175","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178086_bib20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3892\/ijo.2020.5099","article-title":"Anticancer peptide: physicochemical property, functional aspect and trend in clinical application","volume":"57","author":"Chiangjong","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2025.178086_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114996","article-title":"Current research status of anti-cancer peptides: mechanism of action, production, and clinical applications","volume":"164","author":"Chinnadurai","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.178086_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117983","article-title":"Synergistic therapeutic efficacy of selective anticancer complex in triple-negative breast cancer","volume":"185","author":"Cho","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583500000123","article-title":"Electrically gated ionic channels in lipid bilayers","volume":"10","author":"Ehrenstein","year":"1977","journal-title":"Q. Rev. Biophys."},{"issue":"5","key":"10.1016\/j.ejphar.2025.178086_bib24","first-page":"2703","article-title":"Evidence for a direct antitumor mechanism of action of bovine lactoferricin","volume":"22","author":"Eliassen","year":"2003"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178086_bib26","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1074\/jbc.275.6.4230","article-title":"Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity","volume":"275","author":"Feder","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178086_bib27","series-title":"Cancer Today","author":"Ferlay","year":"2024"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2025.178086_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2013.00294","article-title":"From antimicrobial to anticancer peptides. A review","volume":"4","author":"Gaspar","year":"2013","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.ejphar.2025.178086_bib30","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1021\/acs.jcim.4c02072","article-title":"ACP-CLB: an anticancer peptide prediction model based on multichannel discriminative processing and integration of large pretrained protein language models","volume":"65","author":"Geng","year":"2025","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178086_bib31","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3390\/molecules28031148","article-title":"Anti-cancer peptides: status and future prospects","volume":"28","author":"Ghaly","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ejphar.2025.178086_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4103\/RPS.RPS_75_24","article-title":"Exploring the potential of anticancer peptides as therapeutic agents for cancer treatment","volume":"20","author":"Ghavimi","year":"2025","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2025.178086_bib33","article-title":"A sandwich ELISA for the quantification of the anticancer peptide CIGB-552 in human plasma","author":"G\u00f3mez Hern\u00e1ndez","year":"2024","journal-title":"Anal. Biochem."},{"issue":"13","key":"10.1016\/j.ejphar.2025.178086_bib34","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/cmdc.201800204","article-title":"Designing anticancer peptides by constructive machine learning","volume":"13","author":"Grisoni","year":"2018","journal-title":"ChemMedChem"},{"issue":"36","key":"10.1016\/j.ejphar.2025.178086_bib35","doi-asserted-by":"crossref","first-page":"20497","DOI":"10.1039\/C9RA04145A","article-title":"The tetrameric peptide LfcinB (20\u201325)4 derived from bovine lactoferricin induces apoptosis in the MCF-7 breast cancer cell line","volume":"9","author":"Guerra","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejphar.2025.178086_bib36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcis.2021.08.200","article-title":"Rationally designed short cationic \u03b1-helical peptides with selective anticancer activity","volume":"607","author":"Hadianamrei","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejphar.2025.178086_bib37","first-page":"1","article-title":"Bioactive peptides with potential anticancer properties from various food protein sources: status of recent research, production technologies, and developments","author":"Hamdi","year":"2025","journal-title":"Crit. Rev. Biotechnol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24404-1","article-title":"ACPred-BMF: bidirectional LSTM with multiple feature representations for explainable anticancer peptide prediction","volume":"12","author":"Han","year":"2022","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.ejphar.2025.178086_bib39","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bcp.2013.08.008","article-title":"Role of glycosylation in the anticancer activity of antibacterial peptides against breast cancer cells","volume":"86","author":"Han","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178086_bib40","article-title":"Design, synthesis and activity evaluation of reduction-responsive anticancer peptide temporin-1CEa drug conjugates","author":"Han","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib41","doi-asserted-by":"crossref","DOI":"10.1007\/s12559-023-10179-8","article-title":"Interpreting black-box models: a review on explainable artificial intelligence","volume":"16","author":"Hassija","year":"2023","journal-title":"Cognitive Computation"},{"issue":"21","key":"10.1016\/j.ejphar.2025.178086_bib42","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1021\/bi0273563","article-title":"Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37","volume":"42","author":"Henzler Wildman","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2025.178086_bib43","first-page":"135","article-title":"Application of Unnatural Amino Acids to the De Novo Design of Selective Antibiotic Peptides","author":"Hicks","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.ejphar.2025.178086_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3043","article-title":"Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts","volume":"13","author":"Hilchie","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejphar.2025.178086_bib45","first-page":"426","volume":"vol. 99","author":"Hilchie","year":"2015"},{"issue":"2","key":"10.1016\/j.ejphar.2025.178086_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26020444","article-title":"Development of antimicrobial stapled peptides based on magainin 2 sequence","volume":"26","author":"Hirano","year":"2021","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ejphar.2025.178086_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/intimm\/dxw027","article-title":"The present status and future prospects of peptide-based cancer vaccines","volume":"28","author":"Hirayama","year":"2016","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ejphar.2025.178086_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.00571","article-title":"Peptide-drug conjugates and their targets in advanced cancer therapies","volume":"8","author":"Hoppenz","year":"2020","journal-title":"Front. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2025.178086_bib49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbamem.2007.11.008","article-title":"Studies on anticancer activities of antimicrobial peptides","volume":"1778","author":"Hoskin","year":"2008","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejphar.2025.178086_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102355","article-title":"Cationic antimicrobial peptide NRC-03 induces oral squamous cell carcinoma cell apoptosis via CypD-mPTP axis-mediated mitochondrial oxidative stress","volume":"54","author":"Hou","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib51","doi-asserted-by":"crossref","DOI":"10.1049\/syb2.70010","article-title":"ACP\u2010DPE: a dual\u2010channel deep learning model for anticancer peptide prediction","volume":"19","author":"Huang","year":"2025","journal-title":"IET Syst. Biol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178086_bib52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/1535-7163.MCT-10-0811","article-title":"Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework","volume":"10","author":"Huang","year":"2011","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2025.178086_bib53","article-title":"Identification and exploration of anticancer activity of novel peptides isolated from the edible bivalve callista chione in hepatic and Colon cancer cell lines","volume":"14","author":"Hussein","year":"2025","journal-title":"Toxicol. Rep."},{"issue":"5","key":"10.1016\/j.ejphar.2025.178086_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14050997","article-title":"Development of anticancer peptides using artificial intelligence and combinational therapy for cancer therapeutics","volume":"14","author":"Hwang","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejphar.2025.178086_bib55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1535-6108(02)00031-4","article-title":"VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic \u03b2 cell carcinogenesis","volume":"1","author":"Inoue","year":"2002","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ejphar.2025.178086_bib56","first-page":"419","article-title":"Efficacy of a proapoptotic peptide towards cancer cells","volume":"26","author":"J\u00e4kel","year":"2012","journal-title":"In Vivo (Athens)"},{"issue":"4","key":"10.1016\/j.ejphar.2025.178086_bib57","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1021\/acs.biomac.5c00154","article-title":"Hybrid anticancer peptide synergistically improving cancer cell uptake and inducing apoptosis mediated by membrane fusion","volume":"26","author":"Jia","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejphar.2025.178086_bib58","author":"Keeley"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib59","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2024.5711","article-title":"Anti-angiogenic effect of bryopsis plumosa-derived peptide via aquaporin 3 in non-small cell lung cancer","volume":"66","author":"Kim","year":"2024","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2025.178086_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2022.109484","article-title":"Antimicrobial peptides with anticancer activity: today status, trends and their computational design","volume":"733","author":"Kordi","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2025.178086_bib61","series-title":"Anticancer Peptides Market Size Clinical Trials Approval FDA Approved Drugs Insight","year":"2025"},{"issue":"12","key":"10.1016\/j.ejphar.2025.178086_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104206","article-title":"Peptides as innovative strategies to combat drug resistance in cancer therapy","volume":"29","author":"Lamb","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2025.178086_bib63","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1016\/j.csbj.2022.07.043","article-title":"Mlacp 2.0: an updated machine learning tool for anticancer peptide prediction","volume":"20","author":"Le Thi","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2008.05.041","article-title":"Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide","volume":"271","author":"Lee","year":"2008","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.eururo.2005.12.043","article-title":"Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines","volume":"50","author":"Lehmann","year":"2006","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178086_bib66","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/15384047.2014.1003006","article-title":"Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (tregs) in mice","volume":"16","author":"Li","year":"2015","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.ejphar.2025.178086_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4966","article-title":"MA\u2010PEP: a novel anticancer peptide prediction framework with multimodal feature fusion based on attention mechanism","volume":"33","author":"Liang","year":"2024","journal-title":"Protein Sci."},{"issue":"18","key":"10.1016\/j.ejphar.2025.178086_bib68","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.3390\/molecules25184245","article-title":"Peptides with dual antimicrobial\u2013anticancer activity: strategies to overcome peptide limitations and rational design of anticancer peptides","volume":"25","author":"Liscano","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.178086_bib69","article-title":"Peptide\u2010based therapeutic cancer vaccine: current trends in clinical application","author":"Liu","year":"2021","journal-title":"Cell Prolif."},{"issue":"4","key":"10.1016\/j.ejphar.2025.178086_bib70","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/1535-7163.MCT-04-0077","article-title":"Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines","volume":"4","author":"Mader","year":"2005","journal-title":"Mol. Cancer Therapeut."},{"issue":"44","key":"10.1016\/j.ejphar.2025.178086_bib71","doi-asserted-by":"crossref","first-page":"77121","DOI":"10.18632\/oncotarget.20365","article-title":"MLACP: Machine-Learning-Based prediction of anticancer peptides","volume":"8","author":"Manavalan","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib72","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-017-0328-x","article-title":"Evaluation of the use of therapeutic peptides for cancer treatment","volume":"24","author":"Marqus","year":"2017","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2025.178086_bib73","doi-asserted-by":"crossref","DOI":"10.1007\/s10989-024-10621-x","article-title":"Exploring therapeutic potential: a comprehensive review of antimicrobial peptides in oral cancer management","volume":"30","author":"Marunganathan","year":"2024","journal-title":"Int. J. Pept. Res. Therapeut."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib74","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/138920012798356934","article-title":"PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery","volume":"13","author":"Milla","year":"2012","journal-title":"Curr. Drug Metabol."},{"issue":"16","key":"10.1016\/j.ejphar.2025.178086_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612931","article-title":"Peptide-based agents for cancer treatment: current applications and future directions","volume":"24","author":"Nh\u00e0n","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178086_bib76","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/CMAR.S232708","article-title":"Research progress evaluating the function and mechanism of anti-tumor peptides","volume":"12","author":"Pan","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"14","key":"10.1016\/j.ejphar.2025.178086_bib77","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.3390\/nu15143111","article-title":"An updated review summarizing the anticancer efficacy of Melittin from bee venom in several models of human cancers","volume":"15","author":"Pandey","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib78","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2025.178086_bib79","first-page":"1","article-title":"Peptide synthesis. Peptide applications in biomedicine","author":"Petrou","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.ejphar.2025.178086_bib80","first-page":"1391","volume":"vol. 35","author":"Qiao","year":"2019"},{"issue":"5","key":"10.1016\/j.ejphar.2025.178086_bib81","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bib\/bbz088","article-title":"ACPred-Fuse: fusing multi-view information improves the prediction of anticancer peptides","volume":"21","author":"Rao","year":"2019","journal-title":"Briefings Bioinf."},{"issue":"24","key":"10.1016\/j.ejphar.2025.178086_bib82","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/0008-5472.CAN-12-2359","article-title":"Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses Colon cancer","volume":"72","author":"Ren","year":"2012","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ejphar.2025.178086_bib83","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.chemphyslip.2011.09.003","article-title":"Determining the effect of the incorporation of unnatural amino acids into antimicrobial peptides on the interactions with zwitterionic and anionic membrane model systems","volume":"164","author":"Russell","year":"2011","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejphar.2025.178086_bib15","article-title":"Molecular dynamic study on the structure and thermal stability of mutant pediocin PA-1 peptides engineered with cysteine substitutions","author":"Sevim","year":"2024","journal-title":"Probiotics and Antimicrobial Proteins"},{"issue":"2","key":"10.1016\/j.ejphar.2025.178086_bib84","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1096\/fj.02-0280fje","article-title":"Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells","volume":"17","author":"Shadidi","year":"2002","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-84146-0","article-title":"A. pACP-HybDeep: predicting anticancer peptides using binary tree growth based transformer and structural feature encoding with deep-hybrid learning","volume":"15","author":"Shahid","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178086_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108441","article-title":"B. pACPs-DNN: predicting anticancer peptides using novel peptide transformation into evolutionary and structure matrix-based images with self-attention deep learning model","author":"Shahid","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178086_bib87","article-title":"Peptides as multifunctional players in cancer therapy","author":"Sri","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2025.178086_bib88","doi-asserted-by":"crossref","DOI":"10.1039\/b920762g","article-title":"Anticancer mechanism of peptide P18 in human leukemia K562 cells","volume":"8","author":"Tang","year":"2010","journal-title":"Org. Biomol. Chem."},{"issue":"10","key":"10.1016\/j.ejphar.2025.178086_bib89","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/psc.2441","article-title":"Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic\u03b22,2-amino acid","volume":"18","author":"T\u00f8rfoss","year":"2012","journal-title":"J. Pept. Sci."},{"issue":"12","key":"10.1016\/j.ejphar.2025.178086_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122686","article-title":"Role of anti-cancer peptides as immunomodulatory agents: potential and design strategy","volume":"14","author":"Tripathi","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib91","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1038\/srep02984","article-title":"In silico models for designing and discovering novel anticancer peptides","volume":"3","author":"Tyagi","year":"2013","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib93","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib94","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/17518253.2021.1877363","article-title":"Evaluation of greener solvents for solid-phase peptide synthesis","volume":"14","author":"Wegner","year":"2021","journal-title":"Green Chem. Lett. Rev."},{"key":"10.1016\/j.ejphar.2025.178086_bib95","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/bty451","article-title":"ACPred-FL: a sequence-based predictor using effective feature representation to improve the prediction of anti-cancer peptides","author":"Wei","year":"2018","journal-title":"Bioinformatics"},{"issue":"21","key":"10.1016\/j.ejphar.2025.178086_bib96","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1093\/bioinformatics\/btz246","article-title":"PEPred-Suite: improved and robust prediction of therapeutic peptides using adaptive feature representation learning","volume":"35","author":"Wei","year":"2019","journal-title":"Bioinformatics"},{"issue":"S4","key":"10.1016\/j.ejphar.2025.178086_bib97","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-022-04771-2","article-title":"GCNCPR-ACPs: a novel graph convolution network method for ACPs prediction","volume":"23","author":"Wu","year":"2022","journal-title":"BMC Bioinf."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-02107-5","article-title":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"7","key":"10.1016\/j.ejphar.2025.178086_bib99","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200004","article-title":"Anti-cancer peptides: classification, mechanism of action, reconstruction and modification","volume":"10","author":"Xie","year":"2020","journal-title":"Open Biology"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178086_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.imed.2023.08.001","article-title":"Medical artificial intellegence and the Black box problem \u2013 a view based on the ethical principle of \u201cDo No Harm.\u201d","volume":"4","author":"Xu","year":"2023","journal-title":"Intelligent Medicine"},{"key":"10.1016\/j.ejphar.2025.178086_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.04.025","article-title":"ACP-DL: a deep learning long short-term memory model to predict anticancer peptides using high-efficiency feature representation","volume":"17","author":"Yi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejphar.2025.178086_bib102","first-page":"862","volume":"vol. 22","author":"Yu","year":"2020"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178086_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269084","article-title":"BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor","volume":"17","author":"Yu","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.178086_bib104","article-title":"Discovery of anticancer peptides from natural and generated sequences using deep learning","volume":"290","author":"Yue","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.ejphar.2025.178086_bib105","article-title":"CXC chemokine ligand 1 mediates adiponectin-induced angiogenesis in ovarian cancer","volume":"41","author":"Yung-Taek","year":"2019","journal-title":"Tumor Biol."},{"issue":"48","key":"10.1016\/j.ejphar.2025.178086_bib106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40779-021-00343-2","article-title":"Antimicrobial peptides: mechanism of action, activity and clinical potential","volume":"8","author":"Zhang","year":"2021","journal-title":"Military Medical Research"},{"key":"10.1016\/j.ejphar.2025.178086_bib107","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.intimp.2016.02.015","article-title":"Methionine enkephalin, its role in immunoregulation and cancer therapy","volume":"37","author":"Zhao","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.ejphar.2025.178086_bib108","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.3390\/ijms22115630","article-title":"Prediction of anticancer peptides with high efficacy and low toxicity by hybrid model based on 3D structure of peptides","volume":"22","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178086_bib109","doi-asserted-by":"crossref","DOI":"10.47852\/bonviewJDSIS52024821","article-title":"iACP-SEI: an anticancer peptide identification method incorporating sequence evolutionary information","author":"Zheng","year":"2025","journal-title":"Journal of Data Science and Intelligent Systems"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925008404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925008404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:47:05Z","timestamp":1758055625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925008404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":107,"alternative-id":["S0014299925008404"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178086","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling anticancer peptides; from the mechanisms of action to their development through artificial intelligence","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178086"}}